FINWIRES · TerminalLIVE
FINWIRES

KRX:207940

21 stories mentioning KRX:207940Updated 8d ago

Every FINWIRES story that references KRX:207940, newest first.

What are analysts saying about KRX:207940?

Recent broker actions mentioned in FINWIRES coverage. Compiled from wire headlines; not investment advice.

What's the latest news on KRX:207940?

Asia

Nomura Adjusts Samsung Biologics' Price Target to KRW2,200,000 From KRW2,600,000, Keeps at Buy

Samsung Biologics (KRX:207940) has an average rating of buy and mean price target of 2,199,631.50 won, according to analysts polled by FactSet.

KRX:207940

Showing 21-21 of 21

Track with the FINWIRES app suite

FolioX
FolioX
Track KRX:207940 in your portfolio
WheelAI
WheelAI
Analyze KRX:207940 options with the wheel strategy
StockInsider
StockInsider
See market sentiment on KRX:207940